Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

Minimally Invasive Glaucoma Surgery (MIGS) Devices Comprehensive Study by Target (Trabecular Meshwork, Suprachoroidal Space, Others), Surgery (Glaucoma in Conjunction with Cataract, Stand-Alone Glaucoma), Product (MIGS Stents, MIGS Shunts, Other), End User (Hospitals, Ophthalmic Clinics, Others) Players and Region - Global Market Outlook to 2026

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 243 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview:
The minimal invasive glaucoma surgery (MIGS) procedures are expected to grow in the future due to an increase in the demand for surgery devices and government support such as favorable reimbursement policies and foreign direct investment provisions. High demand for minimally invasive glaucoma surgery devices due to various benefits such as reduced surgery time, shorter recovery period, affordability, and low risk of post-surgical complications, including hypotony. The surge in the number of glaucoma care initiatives conducted by the government and several non-governmental organizations is expected to have a positive impact on the adoption of advanced devices.

Growth Drivers
  • Increased Number of Minimally Invasive Surgery Performed Around the Glob
  • High Benefits of Minimally Invasive Surgeries

Market Trends
  • Increase in Focus of Key Players in the Development of MIGS Stents
  • Rise in the Demand for Combined Glaucoma and Cataract Surgeries

Roadblocks
  • Reimbursement Barriers regarding MIGS Devices
  • Availability of alternative treatment methods

Opportunities
  • Increased Research and Development Activities
  • Growth Opportunities in Emerging Markets
  • Growing Public-Private Initiatives to Support Research Activities on Minimally Invasive Surgical Instruments

Challenges
  • Dearth of skilled professionals
  • Lack of Awareness about Glaucoma and Its Treatment Procedures in Underdeveloped Countries


Competitive Landscape:
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Some of the key players profiled in the report are Alcon Inc. (Switzerland), Ellex Medical Lasers Ltd. (Australia), Glaukos Corporation (United States), Allergan Plc (United States), Santen Pharmaceutical Co., Ltd. (Japan), Lumenis (United States), Ivantis, Inc. (United States), SOLX, Inc (United States), iSTAR Medical ( Belgium), InnFocus Inc. (United States), Bausch & Lomb Inc. (United States), Neomedix Corporation (United States), IOPtima (Israel) and Abbott Medical Optics, Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like Topcon Corporation (Japan), New World Medical, Inc (United States) and Carl-Zeiss AG (Germany). Analyst at AMA Research see United States Players to retain maximum share of Global Minimally Invasive Glaucoma Surgery (MIGS) Devices market by 2026. Considering Market by , the sub-segment i.e. will boost the Minimally Invasive Glaucoma Surgery (MIGS) Devices market.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Minimally Invasive Glaucoma Surgery (MIGS) Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Minimally Invasive Glaucoma Surgery (MIGS) Devices, Suppliers of Minimally Invasive Glaucoma Surgery (MIGS) Devices, Wholesalers, Distributors, and Retailers of Minimally Invasive Glaucoma Surgery (MIGS) Devices, Healthcare Industry, Governmental Bodies and Research Firms.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Target
  • Trabecular Meshwork
  • Suprachoroidal Space
  • Others

By Surgery
  • Glaucoma in Conjunction with Cataract
  • Stand-Alone Glaucoma

By Product
  • MIGS Stents
  • MIGS Shunts
  • Other

By End User
  • Hospitals
  • Ophthalmic Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Number of Minimally Invasive Surgery Performed Around the Glob
      • 3.2.2. High Benefits of Minimally Invasive Surgeries
    • 3.3. Market Challenges
      • 3.3.1. Dearth of skilled professionals
      • 3.3.2. Lack of Awareness about Glaucoma and Its Treatment Procedures in Underdeveloped Countries
    • 3.4. Market Trends
      • 3.4.1. Increase in Focus of Key Players in the Development of MIGS Stents
      • 3.4.2. Rise in the Demand for Combined Glaucoma and Cataract Surgeries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target, Surgery, Product, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Value)
      • 5.2.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Target (Value)
        • 5.2.1.1. Trabecular Meshwork
        • 5.2.1.2. Suprachoroidal Space
        • 5.2.1.3. Others
      • 5.2.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Surgery (Value)
        • 5.2.2.1. Glaucoma in Conjunction with Cataract
        • 5.2.2.2. Stand-Alone Glaucoma
      • 5.2.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Product (Value)
        • 5.2.3.1. MIGS Stents
        • 5.2.3.2. MIGS Shunts
        • 5.2.3.3. Other
      • 5.2.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ophthalmic Clinics
        • 5.2.4.3. Others
      • 5.2.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Volume)
      • 5.3.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Target (Volume)
        • 5.3.1.1. Trabecular Meshwork
        • 5.3.1.2. Suprachoroidal Space
        • 5.3.1.3. Others
      • 5.3.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Surgery (Volume)
        • 5.3.2.1. Glaucoma in Conjunction with Cataract
        • 5.3.2.2. Stand-Alone Glaucoma
      • 5.3.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Product (Volume)
        • 5.3.3.1. MIGS Stents
        • 5.3.3.2. MIGS Shunts
        • 5.3.3.3. Other
      • 5.3.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: End User (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Ophthalmic Clinics
        • 5.3.4.3. Others
      • 5.3.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Price)
  • 6. Minimally Invasive Glaucoma Surgery (MIGS) Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alcon Inc. (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ellex Medical Lasers Ltd. (Australia)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Glaukos Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Allergan Plc (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Santen Pharmaceutical Co., Ltd. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lumenis (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ivantis, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. SOLX, Inc (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ISTAR Medical ( Belgium)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. InnFocus Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Bausch & Lomb Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Neomedix Corporation (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. IOPtima (Israel)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Abbott Medical Optics, Inc. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sale, by Target, Surgery, Product, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Value)
      • 7.2.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Target (Value)
        • 7.2.1.1. Trabecular Meshwork
        • 7.2.1.2. Suprachoroidal Space
        • 7.2.1.3. Others
      • 7.2.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Surgery (Value)
        • 7.2.2.1. Glaucoma in Conjunction with Cataract
        • 7.2.2.2. Stand-Alone Glaucoma
      • 7.2.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Product (Value)
        • 7.2.3.1. MIGS Stents
        • 7.2.3.2. MIGS Shunts
        • 7.2.3.3. Other
      • 7.2.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ophthalmic Clinics
        • 7.2.4.3. Others
      • 7.2.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Volume)
      • 7.3.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Target (Volume)
        • 7.3.1.1. Trabecular Meshwork
        • 7.3.1.2. Suprachoroidal Space
        • 7.3.1.3. Others
      • 7.3.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Surgery (Volume)
        • 7.3.2.1. Glaucoma in Conjunction with Cataract
        • 7.3.2.2. Stand-Alone Glaucoma
      • 7.3.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: Product (Volume)
        • 7.3.3.1. MIGS Stents
        • 7.3.3.2. MIGS Shunts
        • 7.3.3.3. Other
      • 7.3.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices by: End User (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Ophthalmic Clinics
        • 7.3.4.3. Others
      • 7.3.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target(USD Million)
  • Table 2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Trabecular Meshwork , by Region USD Million (2015-2020)
  • Table 3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Suprachoroidal Space , by Region USD Million (2015-2020)
  • Table 4. Minimally Invasive Glaucoma Surgery (MIGS) Devices Others , by Region USD Million (2015-2020)
  • Table 5. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery(USD Million)
  • Table 6. Minimally Invasive Glaucoma Surgery (MIGS) Devices Glaucoma in Conjunction with Cataract , by Region USD Million (2015-2020)
  • Table 7. Minimally Invasive Glaucoma Surgery (MIGS) Devices Stand-Alone Glaucoma , by Region USD Million (2015-2020)
  • Table 8. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product(USD Million)
  • Table 9. Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Stents , by Region USD Million (2015-2020)
  • Table 10. Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Shunts , by Region USD Million (2015-2020)
  • Table 11. Minimally Invasive Glaucoma Surgery (MIGS) Devices Other , by Region USD Million (2015-2020)
  • Table 12. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User(USD Million)
  • Table 13. Minimally Invasive Glaucoma Surgery (MIGS) Devices Hospitals , by Region USD Million (2015-2020)
  • Table 14. Minimally Invasive Glaucoma Surgery (MIGS) Devices Ophthalmic Clinics , by Region USD Million (2015-2020)
  • Table 15. Minimally Invasive Glaucoma Surgery (MIGS) Devices Others , by Region USD Million (2015-2020)
  • Table 16. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2015-2020)
  • Table 17. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 18. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 19. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 20. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 21. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 22. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 23. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 24. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 25. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 26. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 27. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 28. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 29. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 30. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 31. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 32. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 33. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 35. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 36. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 37. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 38. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 39. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 40. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 41. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 42. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 43. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 44. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 45. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 46. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 47. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 48. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 49. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 50. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 51. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 52. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 53. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 54. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 55. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 56. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 57. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 58. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 59. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 60. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 61. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 66. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2015-2020)
  • Table 67. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 68. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 69. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 70. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 71. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 72. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 73. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 74. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 75. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 76. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 77. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 78. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 79. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 80. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 81. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 82. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 83. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 84. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 85. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 86. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 87. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 88. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 89. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 90. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 91. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 92. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 93. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 94. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 95. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2015-2020)
  • Table 96. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 97. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 98. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 99. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 100. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 101. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 102. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 103. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 104. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 105. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 106. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 107. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 108. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2015-2020)
  • Table 109. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 110. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 111. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 112. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 113. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 114. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 115. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 116. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 117. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 118. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 119. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 120. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 121. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2015-2020)
  • Table 122. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2015-2020)
  • Table 123. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2015-2020)
  • Table 124. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2015-2020)
  • Table 125. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Target(K Unit)
  • Table 126. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Trabecular Meshwork , by Region K Unit (2015-2020)
  • Table 127. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Suprachoroidal Space , by Region K Unit (2015-2020)
  • Table 128. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Others , by Region K Unit (2015-2020)
  • Table 129. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Surgery(K Unit)
  • Table 130. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Glaucoma in Conjunction with Cataract , by Region K Unit (2015-2020)
  • Table 131. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Stand-Alone Glaucoma , by Region K Unit (2015-2020)
  • Table 132. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Product(K Unit)
  • Table 133. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales MIGS Stents , by Region K Unit (2015-2020)
  • Table 134. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales MIGS Shunts , by Region K Unit (2015-2020)
  • Table 135. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Other , by Region K Unit (2015-2020)
  • Table 136. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by End User(K Unit)
  • Table 137. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Hospitals , by Region K Unit (2015-2020)
  • Table 138. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Ophthalmic Clinics , by Region K Unit (2015-2020)
  • Table 139. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Others , by Region K Unit (2015-2020)
  • Table 140. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2015-2020)
  • Table 141. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 142. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 143. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 144. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 145. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 146. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 147. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 148. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 149. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 150. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 151. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 152. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 153. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 154. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 155. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 156. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 157. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2015-2020)
  • Table 158. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 159. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 160. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 161. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 162. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 163. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 164. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 165. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 166. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 167. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 168. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 169. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 170. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 171. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 172. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 173. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 174. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 175. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 176. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 177. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 178. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 179. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 180. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 181. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 182. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 183. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 184. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 185. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 186. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 187. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 188. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 189. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 190. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2015-2020)
  • Table 191. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 192. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 193. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 194. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 195. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 196. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 197. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 198. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 199. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 200. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 201. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 202. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 203. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 204. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 205. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 206. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 207. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 208. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 209. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 210. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 211. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 212. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 213. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 214. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 215. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 216. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 217. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 218. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 219. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2015-2020)
  • Table 220. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 221. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 222. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 223. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 224. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 225. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 226. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 227. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 228. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 229. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 230. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 231. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 232. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2015-2020)
  • Table 233. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 234. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 235. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 236. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 237. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 238. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 239. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 240. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 241. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 242. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 243. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 244. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 245. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2015-2020)
  • Table 246. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2015-2020)
  • Table 247. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2015-2020)
  • Table 248. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2015-2020)
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target(USD Million)
  • Table 264. Minimally Invasive Glaucoma Surgery (MIGS) Devices Trabecular Meshwork , by Region USD Million (2021-2026)
  • Table 265. Minimally Invasive Glaucoma Surgery (MIGS) Devices Suprachoroidal Space , by Region USD Million (2021-2026)
  • Table 266. Minimally Invasive Glaucoma Surgery (MIGS) Devices Others , by Region USD Million (2021-2026)
  • Table 267. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery(USD Million)
  • Table 268. Minimally Invasive Glaucoma Surgery (MIGS) Devices Glaucoma in Conjunction with Cataract , by Region USD Million (2021-2026)
  • Table 269. Minimally Invasive Glaucoma Surgery (MIGS) Devices Stand-Alone Glaucoma , by Region USD Million (2021-2026)
  • Table 270. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product(USD Million)
  • Table 271. Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Stents , by Region USD Million (2021-2026)
  • Table 272. Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Shunts , by Region USD Million (2021-2026)
  • Table 273. Minimally Invasive Glaucoma Surgery (MIGS) Devices Other , by Region USD Million (2021-2026)
  • Table 274. Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User(USD Million)
  • Table 275. Minimally Invasive Glaucoma Surgery (MIGS) Devices Hospitals , by Region USD Million (2021-2026)
  • Table 276. Minimally Invasive Glaucoma Surgery (MIGS) Devices Ophthalmic Clinics , by Region USD Million (2021-2026)
  • Table 277. Minimally Invasive Glaucoma Surgery (MIGS) Devices Others , by Region USD Million (2021-2026)
  • Table 278. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2021-2026)
  • Table 279. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 280. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 281. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 282. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 283. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 284. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 285. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 286. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 287. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 288. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 289. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 290. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 291. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 292. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 293. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 294. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 295. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2021-2026)
  • Table 296. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 297. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 298. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 299. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 300. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 301. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 302. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 303. China Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 304. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 305. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 306. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 307. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 308. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 309. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 310. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 311. India Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 312. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 313. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 314. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 315. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 316. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 317. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 318. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 319. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 320. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 321. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 322. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 323. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 324. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 325. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 326. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 327. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 328. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2021-2026)
  • Table 329. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 330. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 331. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 332. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 333. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 334. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 335. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 336. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 337. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 338. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 339. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 340. France Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 341. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 342. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 343. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 344. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 345. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 346. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 347. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 348. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 349. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 350. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 351. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 352. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 353. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 354. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 355. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 356. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 357. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2021-2026)
  • Table 358. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 359. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 360. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 361. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 362. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 363. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 364. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 365. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 366. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 367. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 368. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 369. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 370. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Country USD Million (2021-2026)
  • Table 371. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 372. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 373. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 374. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 375. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 376. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 377. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 378. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 379. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 380. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 381. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 382. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 383. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Target USD Million (2021-2026)
  • Table 384. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Surgery USD Million (2021-2026)
  • Table 385. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by Product USD Million (2021-2026)
  • Table 386. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices, by End User USD Million (2021-2026)
  • Table 387. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Target(K Unit)
  • Table 388. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Trabecular Meshwork , by Region K Unit (2021-2026)
  • Table 389. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Suprachoroidal Space , by Region K Unit (2021-2026)
  • Table 390. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Others , by Region K Unit (2021-2026)
  • Table 391. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Surgery(K Unit)
  • Table 392. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Glaucoma in Conjunction with Cataract , by Region K Unit (2021-2026)
  • Table 393. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Stand-Alone Glaucoma , by Region K Unit (2021-2026)
  • Table 394. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by Product(K Unit)
  • Table 395. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales MIGS Stents , by Region K Unit (2021-2026)
  • Table 396. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales MIGS Shunts , by Region K Unit (2021-2026)
  • Table 397. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Other , by Region K Unit (2021-2026)
  • Table 398. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales: by End User(K Unit)
  • Table 399. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Hospitals , by Region K Unit (2021-2026)
  • Table 400. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Ophthalmic Clinics , by Region K Unit (2021-2026)
  • Table 401. Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Others , by Region K Unit (2021-2026)
  • Table 402. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2021-2026)
  • Table 403. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 404. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 405. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 406. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 407. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 408. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 409. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 410. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 411. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 412. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 413. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 414. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 415. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 416. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 417. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 418. Rest of South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 419. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2021-2026)
  • Table 420. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 421. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 422. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 423. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 424. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 425. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 426. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 427. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 428. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 429. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 430. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 431. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 432. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 433. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 434. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 435. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 436. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 437. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 438. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 439. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 440. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 441. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 442. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 443. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 444. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 445. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 446. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 447. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 448. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 449. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 450. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 451. Rest of Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 452. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2021-2026)
  • Table 453. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 454. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 455. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 456. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 457. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 458. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 459. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 460. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 461. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 462. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 463. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 464. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 465. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 466. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 467. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 468. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 469. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 470. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 471. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 472. United Kingdom Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 473. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 474. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 475. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 476. Netherlands Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 477. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 478. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 479. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 480. Rest of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 481. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2021-2026)
  • Table 482. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 483. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 484. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 485. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 486. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 487. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 488. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 489. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 490. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 491. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 492. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 493. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 494. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Country K Unit (2021-2026)
  • Table 495. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 496. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 497. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 498. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 499. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 500. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 501. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 502. United States Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 503. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 504. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 505. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 506. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 507. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Target K Unit (2021-2026)
  • Table 508. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Surgery K Unit (2021-2026)
  • Table 509. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by Product K Unit (2021-2026)
  • Table 510. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales, by End User K Unit (2021-2026)
  • Table 511. Research Programs/Design for This Report
  • Table 512. Key Data Information from Secondary Sources
  • Table 513. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target USD Million (2015-2020)
  • Figure 5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery USD Million (2015-2020)
  • Figure 6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product USD Million (2015-2020)
  • Figure 7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User USD Million (2015-2020)
  • Figure 8. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 9. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 10. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 11. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 12. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 13. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target K Unit (2015-2020)
  • Figure 14. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery K Unit (2015-2020)
  • Figure 15. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product K Unit (2015-2020)
  • Figure 16. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User K Unit (2015-2020)
  • Figure 17. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 18. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 19. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 20. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 21. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 22. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices share by Players 2020 (%)
  • Figure 23. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices share by Players (Top 3) 2020(%)
  • Figure 24. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Alcon Inc. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Alcon Inc. (Switzerland) Revenue: by Geography 2020
  • Figure 28. Ellex Medical Lasers Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 29. Ellex Medical Lasers Ltd. (Australia) Revenue: by Geography 2020
  • Figure 30. Glaukos Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Glaukos Corporation (United States) Revenue: by Geography 2020
  • Figure 32. Allergan Plc (United States) Revenue, Net Income and Gross profit
  • Figure 33. Allergan Plc (United States) Revenue: by Geography 2020
  • Figure 34. Santen Pharmaceutical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Santen Pharmaceutical Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 36. Lumenis (United States) Revenue, Net Income and Gross profit
  • Figure 37. Lumenis (United States) Revenue: by Geography 2020
  • Figure 38. Ivantis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Ivantis, Inc. (United States) Revenue: by Geography 2020
  • Figure 40. SOLX, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 41. SOLX, Inc (United States) Revenue: by Geography 2020
  • Figure 42. ISTAR Medical ( Belgium) Revenue, Net Income and Gross profit
  • Figure 43. ISTAR Medical ( Belgium) Revenue: by Geography 2020
  • Figure 44. InnFocus Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 45. InnFocus Inc. (United States) Revenue: by Geography 2020
  • Figure 46. Bausch & Lomb Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 47. Bausch & Lomb Inc. (United States) Revenue: by Geography 2020
  • Figure 48. Neomedix Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 49. Neomedix Corporation (United States) Revenue: by Geography 2020
  • Figure 50. IOPtima (Israel) Revenue, Net Income and Gross profit
  • Figure 51. IOPtima (Israel) Revenue: by Geography 2020
  • Figure 52. Abbott Medical Optics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 53. Abbott Medical Optics, Inc. (United States) Revenue: by Geography 2020
  • Figure 54. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target USD Million (2021-2026)
  • Figure 55. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery USD Million (2021-2026)
  • Figure 56. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product USD Million (2021-2026)
  • Figure 57. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User USD Million (2021-2026)
  • Figure 58. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 59. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 60. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 61. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 62. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 63. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Target K Unit (2021-2026)
  • Figure 64. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Surgery K Unit (2021-2026)
  • Figure 65. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by Product K Unit (2021-2026)
  • Figure 66. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices: by End User K Unit (2021-2026)
  • Figure 67. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 68. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 69. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 70. MEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
  • Figure 71. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Alcon Inc. (Switzerland)
  • Ellex Medical Lasers Ltd. (Australia)
  • Glaukos Corporation (United States)
  • Allergan Plc (United States)
  • Santen Pharmaceutical Co., Ltd. (Japan)
  • Lumenis (United States)
  • Ivantis, Inc. (United States)
  • SOLX, Inc (United States)
  • iSTAR Medical ( Belgium)
  • InnFocus Inc. (United States)
  • Bausch & Lomb Inc. (United States)
  • Neomedix Corporation (United States)
  • IOPtima (Israel)
  • Abbott Medical Optics, Inc. (United States)
Additional players considered in the study are as follows:
Topcon Corporation (Japan) , New World Medical, Inc (United States) , Carl-Zeiss AG (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation